Recursion Pharmaceuticals Inc (NASDAQ: RXRX): To Buy Or Not To Buy, That Is The Question
The Vanguard Group, Inc. has recently announced that it has increased stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) by 38.41%. After grabbing 15.27 million shares, the institutional investor is now in possession of 4.24 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.33% having worth around $104.6 million. […]
Gains May Be On The Menu For Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.33% valued currently at $104.6 million. In addition, […]
Recursion Pharmaceuticals Inc (RXRX): Street Finally Waking Up
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.33% valued currently at $104.6 million. In addition, […]
There Is Clear Momentum For Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
The Vanguard Group, Inc. has recently announced that it has increased stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) by 38.41%. After grabbing 15.27 million shares, the institutional investor is now in possession of 4.24 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.48% having worth around $80.63 million. […]
Value Hunters: Look To Recursion Pharmaceuticals Inc (RXRX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.48% valued currently at $80.63 million. In addition, […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
With over 6.33 million Recursion Pharmaceuticals Inc (RXRX) shares trading Monday and a closing price of $6.53 on the day, the dollar volume was approximately $41.36 million. The shares have shown a negative half year performance of -26.88% and its price on 11/27/23 lost nearly -4.81%. Currently, there are 183.21M common shares owned by the […]
Why Should You Put Recursion Pharmaceuticals Inc (NASDAQ: RXRX) On Your Portfolio?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.48% valued currently at $80.63 million. In addition, […]
